Article
Autologous tumor-immune effusion co-cultures enable ex vivo functional profiling of radiotherapy-immunotherapy combinations
2026-01-12
Abstract excerpt
<title>Abstract</title> <p> Background Currently, radiotherapy-immunotherapy (RT-IO) combinations provide limited and heterogeneous benefit in human solid cancers and are frequently selected empirically, partly because human models that preserve native, autologous tumor-immune interactions are lacking. We developed patient-derived autologous tumor-immune effusion co-cultures (PATEC) as an <italic>ex vivo</ital...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b938e848-800b-59ec-a270-363b6071e6f8
- DOI
- 10.21203/rs.3.rs-8516163/v1
